354 results found.
This is an outtake from the book The Non-Obvious Guide to Magical meetings (No Matter Who is in the Room), written by Douglas Ferguson &…
Control the Room Podcast: Douglas Ferguson speaks with Michael Wilkinson, CEO and Managing Director of Leadership Strategies, about his path to the International Association of Facilitators Hall of Fame, what makes a great facilitator, and the six P's of preparing a meeting.
Control the Room Podcast: Douglas Ferguson talks to Alison Coward, founder of Bracket, about how to make space for conflict, why there is power in the introduction, and how your team can define who they are as an objective. Listen in to find out how to understand the context of what you're working in, how you can create the environment to do your best work as a team, and why shared empathy across a team is so important.
Arguably one of the most famous Albert Einstein quotes is: “The definition of insanity is doing the same thing over and over again and expecting…
CTR Podcast: Host Douglas Ferguson speaks with Lynda Baker, founder and president of Meeting Solutions Online, about her relationship with IAF and they take a deep dive into the concepts of facilitation and why you don't need to manage or control every part of a conversation.
Treat meeting prep like a surgeon preps for surgery–strategically, meticulously, and with eyes wide open.
Control the Room Podcast: host Douglas Ferguson talks with Karen Holst, LinkedIn Learning expert and co-author of their book Start Within, about how to dive into the book and use it to contribute to your growth journey.
Control the Room Podcast: host Douglas Ferguson talks with Harold Hardaway, co-founder & CEO of Cardigan. They discuss how to utilize quiet during facilitation, how to use ingratiation and equifinality in facilitation, why acknowledgment is so powerful and more.
“Working alone, together.” This is one of the mantras of facilitation. It’s a concept that’s ingrained in my own work as a facilitator–the idea to…
Lumos Pharma is a clinical-stage biotechnology company focused on developing new therapies for people with rare diseases. Its focus is prioritized in areas where the…
